Chung, Youngran. Oxygen reperfusion is limited in the postischemic hypertrophic myocardium. Am J Physiol Heart Circ Physiol 290: H2075-H2084, 2006; doi:10.1152/ajpheart.00619.2005.-Studies have shown that hypertrophied hearts are unusually vulnerable to ischemia. Compromised O 2 supply has been postulated as a possible explanation for this phenomenon on the basis of elongated O 2 diffusion distance and altered coronary vasculature found in hypertrophied myocardium. To examine the postulate, perfused heart experiments followed the metabolic and functional responses of hypertrophic myocardium to ischemia.
HYPERTROPHIED HEARTS show an increased susceptibility to ischemia (1, 9, 15, 31, 39, 53, 55) . The concentric left ventricular (LV) hypertrophy (LVH) is an adaptive response to chronic pressure overload, which involves multistep signaling pathways. After a period of compensated hypertrophic state, the hemodynamics of hypertrophic hearts gradually deteriorate and often culminate in heart failure. However, even before it develops overt hemodynamic failures, hypertrophic myocardium frequently displays signs of abnormalities, including an increased susceptibility to ischemia. Consequently, LVH is an independent risk factor for patients undergoing heart surgery. LVH is also characterized by diminished mechanical and energetic responses to the functionally ischemic conditions induced by high-workload challenges (6) .
Inflammatory and oxidative signals, including TNF-␣ or oxygen free radicals, might contribute to the increased susceptibility of hypertrophic myocardium to ischemia (31, 55) . Yet many studies have also demonstrated an altered energy metabolism in LVH and have suggested a cellular hypoxia (15, 41, 61, 64) . Consistent with possible O 2 limitation, a depressed O 2 consumption in the hypertrophic myocardium, especially under low perfusion pressure, has been reported (9, 61) . These findings suggest that the LVH heart may be partially ischemic even under normal unstressed conditions, increasing its vulnerability to major ischemic events. In a word, O 2 supply of the LVH heart might be so close to being limiting (or already limiting) that an ischemic episode will readily "tip it over the edge."
LVH O 2 limitation may result from a compromised capillary-to-cell O 2 diffusion. Even though the absolute number of capillaries can be increased, capillary proliferation in the pressure-induced LVH heart fails to match the myocyte size increase, resulting in lower capillary density and elongated capillary-to-cell O 2 diffusion distance (15, 23, 43) . At the same time, the increased cell volume-to-surface area ratio of hypertrophied myocytes decreases the effective area of the diffusional plane.
Furthermore, abnormalities of the coronary vasculature may also contribute to hypoxia in LVH. Pressure-induced hypertrophy leads to the loss of coronary flow reserve, narrowed arteriolar lumens, and increased minimal coronary vascular resistance, particularly in the subendocardial region (4, 61) . In effect, either the defect in the conductive (diffusion) and/or convective (flow) component of O 2 delivery can cause O 2 shortage in LVH.
LVH hypoxia, implicated by histological and vascular evidences, nonetheless has eluded a direct demonstration until recently. One of the recent efforts to directly measure O 2 level in the intact tissue is the 1 H NMR detection of myoglobin (Mb) signal, which provides an intracellular O 2 marker in heart and skeletal muscle (20, 60 ). Indeed, a 1 H NMR study (5) of in situ canine hearts examined the oxygenation state in LVH and reported a normal O 2 level. This report then suggests that the LVH O 2 supply in vivo may not be as compromised as has been previously surmised.
Yet to be determined, however, is the effect of the LVH O 2 condition on the ischemia-reperfused heart. As O 2 returns to the O 2 -depleted heart, the abnormalities of O 2 transport in LVH, either diffusive or convective, are likely to be magnified. Therefore, the current study aimed to test the hypothesis that a reduced availability of cellular O 2 is responsible for poor energetic and functional recoveries documented for reperfused LVH hearts. Cellular O 2 level was measured by 1 H NMR signals of Mb. A simultaneous physiological monitoring and interleaved 31 P NMR acquisition traced energetic and functional states of the heart.
Unlike the in situ canine 1 H NMR work (5, 65) , which utilized deoxygenated Mb signal as a counterindex of O 2 concentration ([O 2 ]), the present perfused heart study used the signal that arises from oxygenated Mb. When Mb is bound to O 2 , the ring current-shifted, three-proton signal from Val E11, originally assigned from the isolated protein studies (40, 51) , resonates at Ϫ2.8 parts per million (ppm) in the 1 H NMR spectra of the heart (11) . Although the isolated perfused heart does not approximate in vivo physiology as closely as do the in situ animal models, the isolated perfused heart preparation allows a ready control of perfusion flow, free from the backdrop of nervous and hormonal interactions. A full control of perfusion flow should facilitate understanding the mechanisms behind O 2 limitation, i.e., impaired diffusion versus compromised flow. To that end, the present study alternately utilized constant-flow and constant-pressure perfusion mode. Ischemic and hypoxic perturbations characterized myocardial responses.
MATERIALS AND METHODS

Animal Model
For the hypertrophic model, spontaneously hypertensive rats (SHR) (Taconic Farms, Germantown, NY), 7-9 mo old, were used. In SHR, elevated blood pressure is detected by the second month of age, and, concurrently, LVH develops. The spontaneous and gradual development of hypertension in SHR is considered to mimic human essential hypertension. Age-matched normotensive Wistar-Kyoto (WKY) rats were used as controls. SHR and WKY rats were maintained in a facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. The care and experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee at University of California at Davis.
Rat Heart Perfusion
Rat heart perfusion at 36°C followed the reported methods (7, 25, 54) and was previously described (11) . The isolated heart was placed in a 20-mm diameter NMR tube and anchored on a Teflon plug with holes to permit perfusate overflow. The perfusion medium was KrebsHenseleit buffer containing (in mM) 118 NaCl, 4.7 KCl, 1.2 KH 2PO4, 1.8 CaCl2, 1.2 MgSO4, 20 NaHCO3, and 15 glucose. The perfusate was saturated with 95% O2-5% CO2, which maintained the pH at 7.4 Ϯ 0.05 (SE), and passed through 5-m and 0.45-m Millipore filters. The gas equilibration was achieved by initially bubbling the gas mixture in the perfusate reservoir and later again passing the perfusate through a home-built membrane lung chamber, comprising gas-permeable Dow Corning Silastic tubing (ID, 0.058 in.; OD, 0.077 in.) wrapped around a heat exchanger.
The perfusate was delivered by a peristaltic pump (Rainin RP-1) to the top of the magnet, where the head pressure was set at 100 mmHg, a pressure high enough to allow hypertensive coronary vessels to autoregulate the flow (61) . Coronary flow was measured by collecting the effluent perfusate returning from the heart. For the constant-flow perfusion mode, the buffer chamber on top of the magnet was bypassed, forming a closed delivery system. In both constant-pressure and constant-flow experiments, the perfusate was not recirculated.
When global ischemia was induced, perfusion flow was stopped at two clamping points. During ischemia, the heart and the surrounding perfusate remaining in the NMR tube were maintained at 36°C, with warm air provided by the variable temperature unit in the magnet. For hypoxia experiments, a Cameron gas-mixing flowmeter (GF-4/MP) controlled the fraction of 95% O 2-5% CO2 and 95% N2-5% CO2. The precision of gas mixing was Ϯ 0.1%. With a switch to the different gas-mixing ratio, the equilibration between the gas mixture and the perfusion buffer in the membrane lung unit was completed within ϳ2 min.
Approximately 50% of the perfusate flowing from the heart was withdrawn through a polyethylene catheter inserted close to the pulmonary artery, and the O 2 concentration of the perfusate was measured by a Yellow Springs Instrument (YSI) 5300 O2 meter.
Parallel non-NMR experiments determined empirically the O 2 loss in the perfusion tubing that extends from the heart placed in the magnet to the O 2 meter set up outside the magnet. The measured partial pressure of O2 (PO2) was then corrected accordingly to reflect venous and arterial value. Myocardial O2 consumption rate (MV O2) was calculated from the corrected inflow and outflow O2 measurements and the coronary flow rate.
A saline-filled latex balloon inserted in the LV monitored LV pressure and heart rate (HR) via a strain-gauge transducer (Statham P23 XL), which were traced by an oscillographic recorder (Gould Windograf). The balloon volume was adjusted to give a resting end-diastolic pressure (EDP) of 8 Ϯ 1 mmHg. The rate-pressure product (RPP) was calculated by multiplying HR by LV developed pressure (LVDP). After the perfusion-NMR experiments, hearts were dissected, dried at 80°C for 72 h, and weighed.
Perfusate Metabolite and Enzyme Assays
Perfusate lactate concentration was determined in triplicates by a lactate oxidase method (YSI 2700 Bioanalyzer). Mb leakage from the heart was assessed by optically scanning the perfusate sample (pH 8.2, equilibrated with room air) at the Soret band (410 -420 nm) (3). Creatine kinase (CK) activity in the perfusate was measured by a spectrophotometric enzyme assay (16) . For CK and Mb, total leakage amount was calculated by integrating the measured concentration over the respective time periods of interest.
NMR
An AMX 400-MHz Bruker spectrometer was used to record 1 1 H spectrum, requiring 5 min of signal accumulation (50-ms repetition time). The free induction decays (FIDs) were zero-filled to 2 K and multiplied by an exponential-Gaussian window function. A spline fit smoothed the baseline. The MbO 2 signal was referenced to H2O peak as 4.67 ppm at 36°C, which was in turn calibrated against sodium 3-(trimethylsilyl)propionate-2,2,3,3-d 4 . 31 P NMR spectra were acquired using 60°pulse angle and 2-s repetition time, a pulsing condition known to minimize the signal saturation (54) . The fully relaxed spectra utilized 90°pulse angle with a 20-s repetition time. The 31 P 90°pulse (72 s) was calibrated on 0.1 M phosphate solution. The spectral width was 6,494 Hz; the data size was 4 K. The FIDs were zero-filled to 8 K and apodized with an exponential-Gaussian function to better resolve intra-and extracellular P i signals. 31 Hypoxia experiment. In a separate set of experiments, after normoxic baseline perfusion, hearts were subjected to varying degrees of hypoxia (5-90% O2) for 40 min. Hearts were perfused in the constantflow mode to minimize the flow responses and to focus primarily on the diffusion limitation. One hypoxic step was tested for each (n ϭ 1) experiment to ensure that prehypoxic conditions for all data points were equivalent.
Cellular PO 2 Analysis
Myocardial O2 level was assessed by the 1 H NMR signals of MbO2 (Fig. 1) . Fractional Mb oxygenation,
was determined from the integrated area of the MbO2 peak and intracellular PO2 values were calculated from the relation
where [PO2]50 is the partial pressure of O2 required to half-saturate Mb. A [PO 2]50 of 3.8 mmHg was used for the calculation (3). During the baseline (preischemic and prehypoxic) period, the signal from deoxy-Mb (ϳ78 ppm), which becomes detectable under ischemic or high-workload conditions (12, 20) , was not visible, confirming the high basal oxygenation level of both SHR and WKY hearts. However, ϳ100% preischemic MbO 2 saturation was not assumed, because NMR detection threshold for deoxy-Mb peak can be as high as ϳ20% (12) . In addition, because the current study reports the first attempt to measure 1 H NMR signals of MbO2 in the constant-pressure perfusion mode, additional experiments were carried out to establish the validity of high level baseline MbO 2 saturation. First, the hearts were perfused initially with constant pressure, followed by a constant-flow perfusion at the flow rate 30% above the flow resulting from constant-pressure perfusion. No further increase in MbO 2 intensity was observed by this perfusion. Second, at this increased flow level, perfusate O2 concentration was lowered. Until the level of hypoxia reached 60% of normoxic O2 level, the MbO2 signal intensity did not decrease. These results are thus consistent with Mb-O 2 saturation approaching a plateau.
However, because of the nonlinear nature of Mb-O 2 binding, only a drastic increase in flow rate (ϳ2 times) will reveal NMR detectable signal changes, as long as Mb is Ն75% O 2 saturated. For example, to raise %MbO 2 from 80 to 90%, a 2.3 times increase in PO2 (therefore, ϳ2.3 times flow rate) would be required. Because an excessive perfusion flow can damage the integrity of the heart, such manipulation was not carried out. Therefore, given the nonlinear nature of Mb-O 2 binding and ϳ10% error in NMR detection of MbO2 signal, one is still left with the possibility that the baseline MbO 2 saturation can range between 75 and 100%. As a result, the baseline Y value was assessed numerically by retrofitting MbO 2 data points obtained from the varying hypoxic measurements to the set of hyperbolic Mb-O 2 binding curves predicted for the hypothetical baseline Y values. On the basis of this estimation, Mb was ϳ75% O 2 saturated during baseline perfusion in both SHR and WKY (Table 3 ) rats. Consistent with this numerical estimation, maximal dilation of the coronary arteries with adenosine under potassium arrest (to maximize supply and minimize demand for O 2) increased MbO2 signal intensity by ϳ20% (results not shown). Postischemic Y values were then evaluated by calibrating respective MbO 2 peaks to the baseline spectra.
The degree of baseline MbO 2 saturation thus estimated closely agrees with the results from optical studies (17, 32, 49 ) that reported 72-80% MbO 2 saturation. Yet such a close agreement was unexpected because the optical method detects only the surface layer of myocardium (ϳ0.6-mm penetration depth), whereas NMR measures the whole tissue. Furthermore, the cited optical studies (32, 49) used substantially lower perfusion pressure than the present study, and the resulting coronary flow rate was approximately one-half the flow rate recorded in the current study. Indeed, low O2-carrying capacity of red blood cell-free buffer may not permit full O2 saturation of Mb in the actively metabolizing tissue, which is in agreement with pervasive concerns about saline perfusion. Nevertheless, my experiments (unpublished observations) and the graded hypoxia experiments of others (49) clearly demonstrate that submaximal MbO2 saturation does not have to be equated with submaximal heart function/metabolism. The critical PO2 level below which the function and energy metabolism of the heart start to deteriorate (if defined as 10% drop from the baseline values) corresponds to ϳ55-65% MbO2 saturation level. Therefore, the buffer-perfused heart, despite submaximal MbO2 saturation, can provide a metabolically stable system within the limited time frame.
Another factor that can potentially undermine the accuracy of %MbO2 measurement is the possibility of Mb leakage from the heart as a result of ischemic/hypoxic cellular damage. Some Mb release did occur during postischemic reperfusion in both WKY and SHR. However, Mb loss over the entire experimental protocol was Ͻ5% of total rat heart Mb. Because the error of MbO2 measurement by 1 H NMR is ϳ10%, the inaccuracy introduced by Mb leakage stays within the overall experimental error. In the hearts subjected to hypoxic manipulations, no Mb leakage was detected.
Phosphate Metabolite Analysis
To quantify the absolute concentrations of high-energy phosphate (HEP) metabolites (CrP, Pi, and ␤-ribonucleoside triphosphate), the ventricular balloon was filled with 100 mM phenylphosphonate solution, following the methods described by Kingsley-Hickman et al. (25) . After the baseline 31 P spectra were collected, the balloon was inflated by 0.04 ml, which corresponds to 4 mol of phenylphosphonate signal. The change in phenylphosphonate signal intensity was considered to represent 4 mol of 31 P nuclei and was used to quantify other signals in the spectra. Because balloon inflation increases the workload of the heart and can potentially affect the outcome of ischemic experiments, 31 P signal quantification was carried out in separate experiments (n ϭ 10) that were not included in the experimental data pool. Once the average baseline ATP concentration was determined in this manner, other 31 P signals were quantitated from the fully relaxed spectra obtained at the beginning of each experiment. With the assumption that no significant changes in the longitudinal relaxation time (T1) occur as a result of ischemia (35) , the same T1 correction factor was applied for the partially saturated spectra from preischemic, ischemic, and postischemic periods.
Intracellular pH, reflected by the chemical shift position of the P i peak, was evaluated from the equation
where pK ϭ 6.9, ␦A ϭ ␦ppm of H2PO 4 Ϫ at 3.290 ppm, ␦B ϭ ␦ppm of HPO 4 2Ϫ at 5.805, and ␦o ϭ ␦ppm of observed Pi peak (19) . The ADP level was calculated from the CK equilibrium ADP ϭ ͓ATP͔͓Creatine͔
by using the Keq value of 1.66 ϫ 10 9 M Ϫ1 and the total creatine pool (CrP ϩ creatine) of 68.5 mol/g dry heart weight (59, 63) . The conversion of mol/g dry wt heart to mM was based on wet-to-dry heart weight ratio (Table 1 ) and cytosolic water volume of 0.44 ml/g wet wt heart tissue (22) . From the calculated ADP concentration, the phosphorylation potential was evaluated as
Statistical Analysis
The data are reported as means Ϯ SE. Statistical significance of t-test was accepted at P Ͻ 0.05. The least squares method (Sigma Plot, Jandel Scientific) determined slopes, intercepts, and correlation coefficients of linear regression. The slopes of the regression lines were compared by testing the distribution of t, t ϭ (b1 Ϫ b2)/(Sb1 Ϫ b2), where (b1 Ϫ b2) is the difference of regression slopes and (Sb1 Ϫ b2) is the standard error of the difference of regression slopes.
RESULTS
Anatomical Data
The LV-to-body weight (BW) ratio (LV/BW) was increased by 48% in SHR, showing a moderate degree (ϳ30 -50% increase) of LVH (Table 1) . For the comparable age groups, WKY rats are substantially larger than SHR. To assess whether the larger body size of WKY rats contributed to the underestimation of LV/BW ratio, data from only the comparable weight ranges of SHR and WKY rats (n ϭ 8 total, 400 -500 g range) were also analyzed. The LV/BW ratio of this selected group again showed a significant difference between SHR and WKY rats (30% increase in SHR). Right ventricle (RV)/BW ratio of SHR heart was not changed from normal (Table 1) .
Baseline Physiology and Metabolism
The RPP (LVDP ϫ HR), an index of myocardial mechanical function, was higher in SHR because of higher LVDP. HR was the same as in WKY rats. Despite the increased RPP, the MV O 2 of SHR hearts was unchanged from normal. Consequently, cardiac aerobic efficiency (RPP/MV O 2 ) was increased in SHR. Coronary flow, normalized to the heart weight, was slightly lower in SHR, but the difference was not statistically significant. These results are summarized in Table 2 . Values are means Ϯ SE; n ϭ 8 WKY and n ϭ 9 SHR. LVP, LV pressure; EDP, end-diastolic pressure; LVDP, LV developed pressure; HR, heart rate; RPP, rate-pressure product; MV O2, oxygen consumption; CK, creatine kinase; Mb, myoglobin. Percentage of postischemic RPP (or coronary flow) normalized to the preischemic RPP (or coronary flow) shows that RPP recovers better than coronary flow in WKY, whereas the reverse is true for SHR. CK (or Mb) release is integrated over preischemic (20 min) (Fig. 1, spectrum a, and Table 3 ). Mb was ϳ75% saturated with O 2 in both SHR and WKY hearts during baseline normoxic perfusion (see MATERIALS AND METHODS).
31 P NMR spectra showed that CrP level, CrP/P i ratio, and phosphorylation potential were all increased in SHR (Table 3) . Cellular pH and lactate production rates were unchanged.
Hypoxia
Perfusing with hypoxic buffer did not reveal any relative O 2 limitation in SHR heart. After hypoxia, hearts were reverted to fully oxygenated perfusate to confirm viability. For both SHR and WKY hearts, RPP, MV O 2 , CrP, and MbO 2 (with a small overshoot in CrP and RPP) all returned to the prehypoxic levels (results not shown).
Ischemia
As soon as perfusion flow stops (20-min normothermic global ischemia), RPP starts to decline in both SHR and WKY rats. After 4 min, no detectable (Ͻ0.5%) mechanical activity remains (Table 4 ). The early phase of the RPP drop is caused primarily by the decrease in the systolic pressure. Subsequently, HR declines. At 9 -11 min after the ischemic onset, the contracture (defined in this study as a rise of resting LV pressure by 3 mmHg above preischemic EDP) develops. Although the contracture builds more slowly in SHR, the peak pressure reached during contracture is significantly higher (Table 4) .
In both SHR and WKY rats, global ischemia induces rapid depletion of cellular O 2 ; in the first 2.5-min spectrum, MbO 2 signals are no longer detected (Fig. 1, spectrum b, and Fig. 3A) . b ADP calculation is based on CK near-equilibrium assumption. This assumption should be valid for SHR as well, because SHR hearts (Յ18 mo age) contain normal level of total CK activity (7) . Pi line width is at half-height. Because no other 31 P resonances broaden as a result of reperfusion, Pi line broadening observed during reperfusion appears to reflect multiple chemical shift positions within composite Pi peak rather than broadening of an individual Lorentzian line.
c Postischemic pH values were obtained from the tallest part of composite, often asymmetrical, Pi peak. Errors reported here are Ϯ SE arising from averaging pH values from different hearts (n ϭ 8, WKY; n ϭ 9, SHR) and are not intended to describe heterogeneous pH dispersion implicated by Pi line broadening. NA, not applicable: measurements were not made during no-flow. *Ischemic or postischemic values are significantly different (P Ͻ 0.05) from preischemic baseline values. †SHR data are significantly different (P Ͻ 0.05) from WKY for corresponding conditions (preischemia, ischemia, or postischemia). Values are means Ϯ SE; n, number of rats. RPP measured at 4 min after ischemic onset. TIC, time to the beginning of ischemic contracture; PIC, peak ischemic contracture; TPIC, time to PIC. †SHR data are significantly different (P Ͻ 0.05) from WKY. 31 P NMR spectra, accumulated during the last 5 min of the ischemic period, show no CrP, near-zero ATP, increased P i , and markedly acidified cellular pH (Table 3) . Other than the pronounced pH change, energetic responses of SHR hearts to ischemia were similar to WKY hearts.
Postischemic Recovery
A period of ventricular fibrillation and arrhythmia (ϳ10 min) follows the onset of reflow until the normal sinus rhythm contractions resume. However, even after the normal contraction pattern returns, RPP continues to improve for another ϳ10 -15 min (Fig. 3B) . In SHR, the final postischemic RPP level is significantly lower than preischemic RPP (Table 2; note that in SHR, even after being significantly reduced from the preischemic level, the absolute value of postischemic RPP is comparable to WKY rats, as a result of higher baseline value). In WKY rats, RPP almost fully recovers. The lower %RPP recovery in the SHR heart is the result of lower LVDP recovery (ϳ32% decrease), because HR changes (ϳ15% decrease) are similar in SHR and WKY. Coronary flow, on the other hand, recovers to the depressed level in both SHR and WKY (Table 2 and Fig. 3A) . As a result, %RPP recovery is higher than %coronary flow recovery in WKY rats, whereas the reverse is true for SHR. The decrease in postischemic RPP is paralleled by the depressed MV O 2 , leaving the aerobic efficiency (RPP/MV O 2 ) unchanged from the preischemic values in both SHR and WKY rats. In addition to the difference in RPP recovery, a notable difference in diastolic dysfunction is evident as more than two times higher postischemic EDP in SHR (Table 2) .
In response to reflow, the return of O 2 is swift (Fig. 1,  spectrum c, and Fig. 3A ), yet it recovers to the level significantly lower than baseline oxygenation, particularly in SHR. Concomitant with severely depressed O 2 , HEP metabolite recovery is depressed in SHR (Table 3) . CrP returns to 50% of preischemic level in SHR, whereas it recovers fully in WKY rats. ATP, depressed in both SHR and WKY, is lower in SHR. As a result, postischemic phosphorylation potential in SHR heart is well below the preischemic level, whereas it is unchanged in WKY heart. Intracellular pH remains slightly acidic during reperfusion in both SHR and WKY hearts. Although the average pH values are similar in SHR and WKY hearts, SHR pH shows a pattern of heterogeneous distribution, indicated by the broadened line width of the P i resonance. Lactate production rate, an index of anaerobic glycolysis, nearly doubles from preischemic level in WKY rats. In SHR, it remains the same ( Table 2) .
Irreversible Cell Damage
Although some CK release persists during postischemic reperfusion, total leakage amounts to only ϳ2% of CK present in the rat heart tissue (44). Mb leakage is Ͻ5% of total cellular Mb. Taken together, these results suggest that no appreciable degree of irreversible cellular damage was induced by the current ischemic protocol (Table 2) .
DISCUSSION
Hypertrophic Model and Its Baseline Physiology/Metabolism
The ventricular hypertrophy examined in the present study is a compensated hypertrophy. In SHR, up to 12 mo of age, LVH remains in a compensated state without overt hemodynamic failures (42) . In the current study, 7-to 9-mo-old rats were used. The degree of LV hypertrophy (48%) was moderate, and the signs of heart failure, such as increased RV/BW ratio, pleural effusion, and hepatomegaly, were absent.
In line with the "compensated" nature of hypertrophic hearts in our study, physiological indexes were either normal (cellular PO 2 , coronary flow and MV O 2 ) or supranormal (RPP). Because RPP was increased and MV O 2 was unchanged, cardiac aerobic efficiency (defined as RPP/MV O 2 ratio) was increased in SHR.
Although the contractility of the SHR heart is often overcompensated (14, 24, 39, 53, 61 ) and the energy utilization can be more efficient in LVH (45, 61) , why SHR hearts examined in the current study show higher baseline energy level is not clear. In fact, literature reports are mixed on the basal HEP level in moderate LVH: decreased, normal, or slightly increased (6, 41, 53, 57, 61) . In the case of human LVH patients, either no change (34, 48, 62 ) or varying degrees of reduction in the CrP/ATP ratio (21, 28) have been observed. The latter case and coronary flow data normalized to 100%). With ischemia, O2 quickly drops to nondetectable level in both SHR (F) and WKY (ᮀ) hearts. After reflow, neither flow (}, SHR; ‚, WKY) nor O2 fully recovers. Note that SHR O2 recovery is out of proportion to flow recovery because SHR postischemic flow is only ϳ5% decreased from WKY flow, whereas PO2 of SHR is ϳ69% lower than that of WKY rats. B: rate-pressure product (RPP) and myocardial O2 consumption rate (MV O2) time course. Preischemic values were calibrated as 100%. Arrhythmic heart contractions observed during early reperfusion period are depicted as zero RPPs (F, SHR; ᮀ, WKY). MV O2 traces are shown in lines (dotted line, SHR; solid line, WKY). Because of dead space clearance, MV O2 values obtained during the first 5 min of reperfusion are not reliable and are therefore shown as fictitious "dashed" lines. When NMR acquisition stopped at 35 min of reperfusion, heart function and MV O2 were allowed to recover for additional 5-10 min. These post-NMR data are shown at 80-min time points.
has been documented mostly in the symptomatic patients and correlates with the severity of hypertrophy. Some workers (34, 52) report that the primary hypertrophic cardiomyopathy is more likely to result in an energy decline than the secondary hypertrophy, such as hypertension-induced LVH. In addition, a coexisting heart failure seems to increase the incidence of HEP abnormalities (21, 47) .
Similar to humans, the extent of hypertrophy and the absence/presence of heart failure affect the energy profile in SHR; the energy level of SHR hearts remains normal at Յ18 mo of age and starts to decline as the signs of heart failure become more evident (39, 41, 56) . Experimentally induced LVH models, on the other hand, seem to show the tendency for early metabolic and functional decline even when hypertrophy is moderate (9, 14, 57) .
However, the increased, rather than normal, SHR HEP level observed in the current study is puzzling and may originate from the substrate condition of our heart perfusion. A shift in substrate preference toward glucose is commonly observed in LVH, including SHR (10, 26, 30, 45) . In SHR, glucose transporter-1 (GLUT-1) expression is increased, whereas the GLUT-4 level is normal (26) . Because GLUT-1-mediated transport is driven primarily by the glucose concentration gradient and glucose was the only substrate used in our study (in relatively high concentration and in the absence of insulin), there is a possibility that SHR hearts utilized the substrate more efficiently than WKY hearts.
Although the point was not emphasized, a report of a glucose-perfused heart study (41) showed an apparent increase in the CrP/ATP ratio in 10-mo-old SHR (1.83 Ϯ 0.09) over that of WKY (1.67 Ϯ 0.07) rats. A second perfusion study (7) that used glucose as the only substrate described the increased CrP/P i and CrP/ATP ratios in 18-mo-old SHR, compared with 12-mo-old SHR, suggesting a possible progression with age of glucose preference (comparison with normotensive rat was not presented in this study). Given the vulnerability of LVH hearts to lower perfusion pressure (53, 61) , different perfusion pressures used in various studies could also contribute to varying HEP results.
Baseline O 2 Level in Hypertrophic Heart
MbO 2 signal obtained from SHR hearts during baseline perfusion was of the same intensity as from WKY hearts (Table 3) , indicating a normal basal O 2 level in SHR. However, it is inherently difficult to determine PO 2 differences under O 2 abundant conditions; due to nonlinear Mb-O 2 binding, wideranging values (from ϳ11 to infinite mmHg) result when PO 2 is calculated from Ն75% O 2 -saturated Mb (see Eq. 2 in MATERIALS AND METHODS). For a more precise comparison, O 2 measurements were made in this study under varying degrees of hypoxic conditions that would bring Mb-O 2 saturation below ϳ70%, so that PO 2 values can be derived from a relatively linear portion of the Mb-O 2 binding curve. In these experiments, hearts were perfused in the constant-flow mode to minimize the flow responses to hypoxia and to focus primarily on the capillary-to-cell O 2 diffusion.
Even hypoxic manipulations, however, failed to reveal any further cellular PO 2 reduction in SHR (Fig. 2) In summary, SHR hearts show no reduced O 2 availability in the baseline as well as hypoxic conditions.
Postischemic Functional Recovery and O 2
Increased vulnerability to ischemia is well recognized among advanced stage LVH (1, 9, 15, 31, 55) . Ischemic responses of fully compensated LVH hearts, however, are more controversial (24, 53) . In the current study, despite its normal O 2 level and well-compensated heart function/metabolism in the basal state, the response of SHR hearts to ischemia was drastically different from normal hearts, displaying a pronounced contractile and metabolic dysfunction. Certainly, preischemic myocardial O 2 limitation is not a prerequisite for postischemic dysfunction in LVH. is further decreased in SHR in proportion to the degree of RPP depression (Fig. 4A ). Quantitatively matching with lower O 2 / RPP is the lower CrP level in SHR (Fig. 4B ), which implies a Tables 1-4 and Figs. 1 and 3 ) and constant-flow (n ϭ 10 SHR; n ϭ 7 WKY hearts) reperfusion experiments. To factor out flow effect from O2 effect, some hearts were reperfused in constant-flow mode at preischemic flow rate of each individual heart. Constant-flow reperfusion improved oxygenation and function in both SHR and WKY hearts. Corresponding MV O2 data points (‚) show similar %changes as RPP. Regression line was drawn through MV O2 data points. RPP data points were excluded from linear regression. B: RPP vs. creatine phosphate (CrP). Postischemic RPP and CrP were normalized to preischemic values. reduced aerobic energy turnover. This point is reinforced by the lower MV O 2 (Table 2 and Fig. 4A ). The excellent correlation between RPP, [O 2 ], [CrP] , and the oxidative energy turnover rate (MV O 2 ) then indicates a probable sequence of events occurring in the postischemic SHR hearts; poor O 2 reperfusion leads to aerobic energy failure, which then leads to depressed heart function.
Proposed mechanisms for compromised oxidative phosphorylation in postischemic heart include mitochondrial injury (38, 50) or excessive cytosolic [Ca 2ϩ ]-by collapsing mitochondrial membrane potential or by competing with ADP for the entry into mitochondria (14, 36, 37) . In our study, permanent mitochondrial damage is not likely to have happened, because 1) markers for irreversible cell damage, CK and Mb release, were low and 2) RPP/MV O 2 coupling efficiency normalized back to the preischemic level in both SHR and WKY rats. This means that RPP and MV O 2 were reduced to the same degree from their respective preischemic levels. As a result, the RPP/MV O 2 ratio, which was higher in SHR hearts during baseline perfusion, remained higher in SHR even during reperfusion.
It is also evident that the kinetic control of oxidative phosphorylation by [ADP] or [P i ] is not a dominant mechanism during reperfusion. If this were the overriding mechanism, given higher levels of both, SHR hearts should be at an advantage. Nor is the thermodynamic control by phosphorylation potential at work. If it were, again, the oxidative phosphorylation of SHR hearts should be more robust than WKY hearts. A kinetic control by O 2 supply, on the other hand, is conspicuous (Fig. 4A) Nevertheless, the rate of reoxygenation, i.e., how fast O 2 returns to the ischemic myocardium, is not likely a limiting factor. Although some reports (9) suggested that a delay in O 2 return caused by elongated diffusion distance may contribute to postischemic dysfunction in LVH, our data show that MbO 2 recovery is completed during the first postreflow 1 H NMR acquisition. Given 2.5-min 1 H NMR signal averaging and ϳ10% error, if a linear MbO 2 increase is assumed, cellular O 2 would approach a new steady state within ϳ30 s after reperfusion is commenced. In similar reasoning, O 2 depletion during ischemia is also expected to be complete within ϳ30 s. The latter estimation agrees well with the optically measured PO 2 decline rate recently reported on ischemic mouse skeletal muscle (33) .
In contrast to rapid O 2 return, however, the steady-state RPP is not attained until ϳ20 -25 min after reperfusion (Fig. 3B ). In the current study, ventricular fibrillation and tachycardia, which were resolved faster in SHR than WKY rats, characterized the period immediately following the reflow. Even after the sinus rhythm returned, RPP did not instantaneously return to the final level but gradually increased for another 10 -15 min. The prevalence of postreflow arrhythmia and delayed RPP recovery has been a typical observation in many ischemia studies (2, 8, 53, 54) .
The disparate recovery time courses between RPP and O 2 implicate the role of O 2 as necessary but not sufficient for the postischemic functional recovery. The role of O 2 may actually change over the course of the recovery process. In the early reperfusion period, the presence of O 2 is not enough to eliminate electrophysiological disturbances of the postischemic hearts. During 10 -25 min of reperfusion, a degree of coupling inefficiency between oxidative metabolism and contractile function persists (Fig. 3, A and B) (Fig. 3, A and B) show that it does. Whether mitochondrial ATP synthesis is uncoupled from MV O 2 is difficult to judge from the current data. The probability, however, seems low; other researchers reported a rapid CrP recovery (2, 9, 54, 56) or an unchanged P/O ratio (46) under similar experimental conditions. Thus the dissociation seems to occur along the steps between ATP synthesis and muscle contraction, which apparently is mediated by factor(s) other than O 2 .
Origin of O 2 Limitation in Reperfused SHR Hearts
As discussed in INTRODUCTION, an elongation of O 2 diffusion distance in LVH can limit O 2 supply. Such O 2 limitation, however, was not observed under nonischemic (baseline and hypoxic) conditions. Therefore, the anatomical change, i.e., myocyte hypertrophy, is not likely the underlying mechanism for postischemic O 2 deficit; cell size would not change selectively in SHR after ischemia. Although postischemic edema can potentially increase the physical dimensions of myocyte and interstitial space, there is no evidence that edema was more severe in SHR hearts, because the wet-to-dry heart weight ratio was virtually identical between SHR and WKY hearts (Table 1) .
If it is not the diffusion limitation imposed by myocyte hypertrophy, is it then possible that SHR hypoxygenation is vascular in origin? Reversible or irreversible circulatory disturbances are frequently observed in the postischemic myocardium (9, 27, 29) . Indeed, coronary flow decreased after ischemia in both SHR and WKY hearts. Yet, curiously enough, relative flow recovery in SHR is almost comparable to WKY (only ϳ5% difference). Consequently, postischemic O 2 level in SHR is disproportionately lower than what can be accounted for by flow reduction (Fig. 3A) . Even constant-flow reperfusion (Fig. 4A) , which significantly improved O 2 /RPP, failed to abolish the difference between SHR and WKY recoveries. Therefore, the postischemic underoxygenation of SHR hearts cannot be fully explained by the flow per se.
The quantitative mismatch between reperfusion flow and O 2 suggests the possibility that the bulk flow is shunted away from the nutritive microvessels. Exacerbated diastolic dysfunction in SHR hearts may play a role here. In the isovolumically contracting hearts, as in the present study, the increased EDP is a direct manifestation of decreased diastolic chamber distensibility and increased wall stress, which should raise extravascular compressive forces (58) . It is then conceivable that the elevated tissue pressure in SHR promotes channeling the flow through the arteriovenous shunts within epicardial conduit vessels, bypassing the compressed intramyocardial vessels. The apparent "dumping" of O 2 into the venous drainage is also reflected in the significantly increased venous PO 2 , shown in SHR during reperfusion (Table 3) .
Because the subendocardial layer of myocardium experiences the highest tissue pressure during ventricular contraction and possibly during the diastolic phase as well (13) , if increased extravascular compressive force is the mechanism, hypoxic myocardial regions are likely to concentrate in the subendocardium. Indeed, it has been repeatedly documented that the subendocardium is functionally and energetically the most vulnerable myocardial region in LVH. The clue for regionally heterogeneous O 2 reperfusion can be found in the line width of P i resonance. After ischemia, SHR P i peak broadens 2.7 times more than WKY, indicating more uneven pH distribution. Because it is expected that underoxygenated cells acidify, pH heterogeneity implies a presence of O 2 heterogeneity.
In conclusion, the compensated LVH heart is well oxygenated during baseline conditions. Yet it is markedly underoxygenated during postischemic reperfusion, the level of which is critically related to the depressed functional recovery. The role of reperfused O 2 , however, is time dependent. During early reperfusion, factor(s) other than O 2 appear to limit functional recovery. It is when the mechanical function of the heart approaches a new steady state that O 2 becomes a dominant factor. Meanwhile, the finding of a normal baseline O 2 level in SHR hearts indicates that preischemic hypoxia is not required to provoke postischemic dysfunction in LVH.
